Biotech · Private company
Mylan Specialty, LP
Track this companyFree. Adds Mylan Specialty, LP to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- MR-107A-02Phase 2 · Acute PainClinicalTrials.gov · fetched Nov 12, 2026
- SilibininPhase 2 · Amatoxin PoisoningClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following HerniorrhaphyPHASE3 · COMPLETED · started Dec 29, 2023ClinicalTrials.gov NCT06215859 · fetched Nov 12, 2026
- Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following BunionectomyPHASE3 · COMPLETED · started Dec 29, 2023ClinicalTrials.gov NCT06215820 · fetched Nov 12, 2026
- Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.PHASE2 · COMPLETED · started Mar 31, 2022ClinicalTrials.gov NCT05317312 · fetched Nov 12, 2026
- Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom PoisoningPHASE2 · TERMINATED · started Nov 10, 2009ClinicalTrials.gov NCT00915681 · fetched Nov 12, 2026